Blue Horseshoe Stocks: PZOO Update, Commenting on the Marijuana Sector

Pazoo, Inc. PZOO

So far we’ve been very happy with the way PZOO has performed since we brought it into the mix to start the week. Our assertion that the PZOO chart was on the cusp of making a nice move proved accurate; after starting out at a low of .0225 on Monday, the stock broke through its 50DMA and traded as high as .031 during yesterday’s session (+38%).

Volume picked up as well, with the stock trading 2.6M shares on the day, which works out to more than 3.5X the 3-month average.

So this new play that has us interested on a long-term basis (for reasons stated in our initial report) has also shown that it has some real short-term potential as well. We also caught a fresh PR this morning, which you’ll find below the following snapshot of the PZOO chart:

WHIPPANY, NJ–(Marketwired – Oct 22, 2014) – Pazoo, Inc. (OTCQB: PZOO) (German WKN#: A1J3DK) is pleased to announce its medical marijuana testing laboratory partner MA & Associates, LLC has hired its first lab technician, Mr. Brad Gore. Further, the build-out for the testing facility began last week. Now that the asbestos abatement was done, actual construction to the facility will begin.

MA & Associates, LLC felt it necessary to begin the build-out of the testing facility and to begin hiring all necessary personnel prior to the State of Nevada issuing licenses to qualified applicants on November 3rd >> FULL PR

PZOO is dually involved with the continued development of its health and wellness online portal at PAZOO.COM as well as its majority stake in a medical marijuana testing firm in Nevada. For those who might have missed our special report on the stock Monday, you can find a copy here: PZOO REPORT


Marijuana Sector Reminder

We also want to touch briefly on our ongoing interest in other medical and legal marijuana plays. For over two years we’ve tracked, and continue to monitor the sector as a whole, with huge winners coming in the form of MJNA, CBIS, HEMP, GRNH, TRTC, ERBB, and so many others.

We recently reminded everyone that we’d be on the lookout for the cannabis space to heat up as we approach a voting season with an unprecedented number of marijuana initiatives on ballots across the country.

This Monday, a federal court will hear evidence contesting that the US Government’s classification of marijuana as a Schedule 1 substance (which ridiculously makes it equal to heroin in the eyes of federal law) is unfounded. Several doctors are prepared to challenge the scientific and medical validity of government claims. If truth and reason win the day, it could be a big step toward  furthering the cause of cannabis acceptance nationwide. >>> READ ARTICLE


Extended Watchlist:
IBIO, RGLS, CLF, BBLU, ZAZA